Please use this identifier to cite or link to this item:
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Aged,Aged, 80 and over,Antineoplastic Combined Chemotherapy Protocols/*pharmacokinetics/*therapeutic use,Carcinoma, Non-Small-Cell Lung/*drug therapy/mortality,Cisplatin/administration & dosage/adverse effects/pharmacokinetics,Deoxycytidine/administration & dosage/adverse effects/analogs &,derivatives/pharmacokinetics,Female,Humans,Kaplan-Meier Estimate,Lung Neoplasms/*drug therapy/mortality,Male,Maximum Tolerated Dose,Middle Aged,Salvage Therapy/adverse effects
ISSN: 0008-543X
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Froudarakis-2008-Phase 1 trial of lip.pdf146.96 kBAdobe PDFView/Open    Request a copy

This item is licensed under a Creative Commons License Creative Commons